GIVE MISS CALL ON :- +91 99774 99927



Market Live: Nifty likely to open higher.

The Nifty50 is expected to open higher on Thursday tracking Asian markets which were trading higher on hopes for a thaw in U.S.-China trade frictions and expectations that the European Central Bank will kick off another wave of monetary easing by global central banks. U.S. President Donald Trump agreed to delay an additional increase in tariffs on Chinese goods by two weeks at the request of China Vice Premier Liu He as a gesture of goodwill, said a Reuters report. Investors also await an ECB meeting later on Thursday to see how far policymakers will go to support a flagging economy, given the risks posed by Britain divorce from the European Union, commonly referred to as Brexit, it said. Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 37 points gain or 0.34 percent. Nifty futures were trading around 11,074-level on the Singaporean Exchange.

Global Market:

Asian Markets: Asian markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.24% while the Hang Seng is up 0.23%. The Nikkei 225 is not trading.
US Markets: North and South American markets finished higher today with shares in U.S. leading the region. The S&P 500 is up 0.72% while Brazil’s Bovespa is up 0.40% and Mexico’s IPC is up 0.38%.
European Markets: European markets finished higher today with shares in London leading the region. The FTSE 100 is up 0.96% while Germany’s DAX is up 0.74% and France’s CAC 40 is up 0.44%.

Major Headlines of the day:

Rupee stands at 71.42 per dollar.

Alkem Labs gets 4 observations from USFDA for St. Louis facility, The Company’s manufacturing facility located at St. Louis, Fenton Logistics Park, US, was inspected from 16th August, 2019, to 22nd August, 2019.

SBI board approves divestment of at least 3.5% in SBI Life Insurance, The divestment would be carried out to achieve the minimum public shareholding threshold of 25%.

Dr Reddys launches Fosaprepitant for injection in the US, The EMEND® for Injection brand had an U.S. sales of approximately $279mn MAT for the most recent twelve months ending in July 2019 according to IQVIA Health.

Trend in FII flows:- The FIIs were Net Value of Rs 266.89 segment while the DIIs were Net Value of 1132.42 the provisional figures.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Leave a Reply


Ouch! There was a server error.
Retry »

Sending message...


CapitalStars FORUM